Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jhep.2024.12.036 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Reply to Letter to the Editor: 'ALT and Novel Fibrosis Scores for Risk Stratification of Pediatric MASLD'.
Clin Gastroenterol Hepatol
August 2025
Department of Paediatric Gastroenterology, Emma Children's Hospital, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands; Amsterdam Gastroenterology Endocrinology Metabolism Research Institute, Amsterdam, The Netherlands; Amsterdam Reproduction and Development Research Instit
Editorial: High Baseline ALT Level Confers Risk of Hepatic Adverse Events During Immune Checkpoint Inhibitors Treatment: A Call for Caution-Authors' Reply.
Aliment Pharmacol Ther
February 2025
Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Reply to: "ALT to qHBsAg ratio predicts HBsAg seroclearance in HBeAg-negative patients receiving Peg-IFNα based therapy".
J Hepatol
May 2025
Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Hong Kong Special Administrative Region of China; State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong Special Administrative Region of China. Electronic address:
Reply to: "Community health strategies for chronic hepatitis B: Advancing care with the ALT/qHBsAg ratio".
J Hepatol
March 2025
Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Hong Kong SAR; State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong SAR. Electronic address:
Editorial: Redefining liver health-Personalised approach to assessment of serum ALT in clinical practice. Authors' reply.
Aliment Pharmacol Ther
August 2024
Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, California, USA.